Mary Jane Burton Selected Research

Mary Jane Burton Research Topics

5	Infections 01/2019 - 07/2009
3	Coinfection 01/2017 - 07/2009
2	Rheumatoid Arthritis 01/2017 - 05/2015
2	Fibrosis (Cirrhosis) 07/2013 - 05/2011
2	Endocarditis 02/2013 - 06/2008
2	Chronic Hepatitis C 08/2012 - 05/2011
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Hepatitis C 01/2018
1	Hepatitis B 05/2015
1	Virus Diseases (Viral Diseases) 12/2012
1	Syphilis 07/2009
1	Sepsis (Septicemia) 04/2008
1	Fournier Gangrene 04/2008

3	Biological ProductsIBA 01/2017 - 12/2012
2	Antirheumatic Agents (DMARD)IBA 01/2017 - 05/2015
2	InterferonsIBA 07/2013 - 08/2012
2	Ribavirin (Virazole)FDA LinkGeneric 07/2013 - 08/2012
2	Pharmaceutical PreparationsIBA 11/2010 - 07/2009
1	Antiviral Agents (Antivirals)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Alanine Transaminase (SGPT)IBA 05/2015
1	Surface Antigens (Surface Antigen)IBA 05/2015
1	DNA (Deoxyribonucleic Acid)IBA 05/2015
1	TroponinIBA 02/2013
1	telaprevirIBA 08/2012
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 08/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2011
1	Crack CocaineIBA 07/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2008
1	Panton-Valentine leukocidinIBA 04/2008

4	Therapeutics 01/2017 - 08/2012
1	Drug Therapy (Chemotherapy) 01/2019
1	Blood Transfusion (Blood Transfusions) 11/2010
1	Antibiotic Prophylaxis 06/2008